David Eidelberg
#101,944
Most Influential Person Now
American neurologist
David Eidelberg's AcademicInfluence.com Rankings
David Eidelbergmedical Degrees
Medical
#1437
World Rank
#1776
Historical Rank
#380
USA Rank
Neurology
#137
World Rank
#203
Historical Rank
#40
USA Rank
Download Badge
Medical
David Eidelberg's Degrees
- Doctorate Medicine Columbia University
- PhD Neuroscience Columbia University
Why Is David Eidelberg Influential?
(Suggest an Edit or Addition)According to Wikipedia, David Eidelberg is an American neuroscientist who is a professor of Neurology and Molecular Medicine at the Zucker School of Medicine. He is a neuroscientist best known for applying functional imaging of the brain to study neurological diseases.
David Eidelberg's Published Works
Published Works
- Transplantation of embryonic dopamine neurons for severe Parkinson's disease. (2001) (1129)
- Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial (2007) (996)
- The Metabolic Topography of Parkinsonism (1994) (428)
- Stereotactic ventral pallidotomy for Parkinson's disease (1995) (408)
- FDG PET in the differential diagnosis of parkinsonian disorders (2005) (386)
- Changes in network activity with the progression of Parkinson's disease. (2007) (377)
- Metabolic brain networks in neurodegenerative disorders: a functional imaging approach (2009) (345)
- Patterns of regional brain activation associated with different forms of motor learning (2000) (339)
- Network modulation in the treatment of Parkinson's disease. (2006) (324)
- Functional brain networks in DYT1 dystonia (1998) (316)
- Metabolic brain networks associated with cognitive function in Parkinson's disease (2007) (314)
- Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis (2010) (289)
- Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility (2007) (288)
- Cerebellothalamocortical Connectivity Regulates Penetrance in Dystonia (2009) (285)
- Increased anterior cingulate and caudate activity in bipolar mania (2000) (283)
- Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. (1999) (278)
- Inferior parietal lobule. Divergent architectonic asymmetries in the human brain. (1984) (276)
- The Metabolic Topography of Normal Aging (1996) (261)
- Dyskinesia after fetal cell transplantation for parkinsonism: A PET study (2002) (255)
- Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year. (1990) (248)
- Differential cortical and subcortical activations in learning rotations and gains for reaching: a PET study. (2004) (247)
- Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease (2008) (219)
- The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies (1990) (215)
- Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects (2011) (215)
- The role of radiotracer imaging in Parkinson disease (2005) (205)
- Impaired sequence learning in carriers of the DYT1 dystonia mutation (2003) (204)
- Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. (1993) (194)
- Progressive polyradiculopathy in acquired immune deficiency syndrome (1986) (187)
- Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. (2001) (182)
- Abnormalities in Metabolic Network Activity Precede the Onset of Motor Symptoms in Parkinson's Disease (2010) (182)
- Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease (2007) (180)
- Thalamic metabolism and symptom onset in preclinical Huntington's disease. (2007) (179)
- Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. (2001) (179)
- An Examination of Executive Dysfunction Associated with Frontostriatal Circuitry in Parkinson's Disease (2006) (178)
- Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes (2010) (176)
- Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. (1996) (176)
- Thrombotic cerebral vasculopathy associated with herpes zoster (1986) (176)
- Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. (2016) (172)
- Early differential diagnosis of Parkinson's disease with 18F‐fluorodeoxyglucose and positron emission tomography (1995) (169)
- The metabolic topography of idiopathic torsion dystonia. (1995) (167)
- Positron emission tomographic studies in restless legs syndrome (1999) (166)
- Abnormal metabolic networks in atypical parkinsonism (2008) (164)
- Regional metabolic correlates of surgical outcomes following unilateral pallidotomy for parkinson's disease (1996) (163)
- Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia (2017) (161)
- Metabolic correlates of levodopa response in Parkinson’s disease (2001) (160)
- The metabolic anatomy of Tourette's syndrome (1997) (160)
- Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation (2005) (158)
- Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease (2006) (155)
- Dopamine transporter imaging with fluorine-18-FPCIT and PET. (1998) (153)
- The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. (1991) (148)
- Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging (2011) (148)
- Functional networks in motor sequence learning: Abnormal topographies in Parkinson's disease (2001) (146)
- Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues (2011) (145)
- The metabolic topography of essential blepharospasm (2000) (145)
- Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. (2001) (144)
- Assessment of the progression of Parkinson's disease: a metabolic network approach (2007) (143)
- Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. (2002) (143)
- Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease (1993) (141)
- Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. (1995) (139)
- Abnormal metabolic network activity in REM sleep behavior disorder (2014) (138)
- Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease (2008) (132)
- Metabolic brain networks in translational neurology: Concepts and applications (2012) (132)
- Abnormal structure-function relationships in hereditary dystonia (2009) (129)
- Metabolic correlates of pallidal neuronal activity in Parkinson's disease. (1997) (129)
- Subthalamic Glutamic Acid Decarboxylase Gene Therapy: Changes in Motor Function and Cortical Metabolism (2007) (128)
- Cerebral glucose metabolism in women with panic disorder. (1998) (128)
- Regional metabolism in primary torsion dystonia (2004) (125)
- Learning and consolidation of visuo-motor adaptation in Parkinson's disease. (2009) (123)
- Reproducibility of regional metabolic covariance patterns: comparison of four populations. (1999) (122)
- Symmetry and asymmetry in the human posterior thalamus. I. Cytoarchitectonic analysis in normal persons. (1982) (120)
- Functional correlates of pallidal stimulation for Parkinson's disease (2001) (120)
- Primary dystonia: Is abnormal functional brain architecture linked to genotype? (2002) (118)
- Stereotactic pallidotomy for Parkinson's disease (1997) (115)
- Abnormal striatal and thalamic dopamine neurotransmission (2009) (113)
- Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder. (2014) (113)
- Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study. (2007) (113)
- Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice (2011) (113)
- Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism (2004) (112)
- [11C]Raclopride‐PET studies of the Huntington's disease rate of progression: Relevance of the trinucleotide repeat length (1998) (112)
- Microstructural white matter changes in carriers of the DYT1 gene mutation (2004) (110)
- Executive processes in Parkinson's disease: FDG‐PET and network analysis (2004) (109)
- A New Approach to Spatial Covariance Modeling of Functional Brain Imaging Data: Ordinal Trend Analysis (2005) (109)
- Preclinical Huntington's disease: Compensatory brain responses during learning (2006) (109)
- The metabolic anatomy of tremor in Parkinson's disease (1998) (106)
- Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features (2009) (103)
- Microstructural white matter changes in primary torsion dystonia (2008) (102)
- The differential effect of PD and normal aging on early explicit sequence learning (2003) (102)
- Striatal 18F-DOPA Uptake: Absence of an Aging Effect (1993) (101)
- Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET (1998) (101)
- Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study (2002) (100)
- Hippocampal and anterior cingulate activation deficits in patients with geriatric depression. (2001) (98)
- Network imaging biomarkers: insights and clinical applications in Parkinson's disease (2018) (98)
- Effects of Serotonin Transporter Promoter Polymorphisms on Serotonin Function (2004) (97)
- Effects of levodopa on motor sequence learning in Parkinson’s disease (2003) (96)
- Relationship Between Self-reported Apathy and Executive Dysfunction in Nondemented Patients With Parkinson Disease (2007) (93)
- Increased sensorimotor network activity in DYT1 dystonia: a functional imaging study. (2010) (93)
- A disease-specific metabolic brain network associated with corticobasal degeneration. (2014) (92)
- Functional brain networks and abnormal connectivity in the movement disorders (2012) (91)
- Symmetry and asymmetry in the human posterior thalamus. II. Thalamic lesions in a case of developmental dyslexia. (1982) (91)
- Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach. (2002) (88)
- Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. (1994) (87)
- Metabolic changes following subthalamotomy for advanced Parkinson's disease (2001) (87)
- The functional neuroanatomy of geriatric depression (2009) (87)
- Metabolic network as a progression biomarker of premanifest Huntington's disease. (2013) (87)
- Tc‐99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism (2002) (85)
- Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. (2008) (83)
- Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers (2017) (82)
- Metabolic resting-state brain networks in health and disease (2015) (81)
- 19F NMR imaging of blood oxygenation in the brain (1988) (81)
- Imaging essential tremor (2010) (80)
- Parkinson's disease cognitive network correlates with caudate dopamine (2013) (80)
- Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity. (1987) (80)
- Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics (2004) (79)
- Enhancement of brain activation during trial-and-error sequence learning in early PD (2003) (78)
- Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease (2001) (78)
- Learning networks in health and Parkinson's disease: Reproducibility and treatment effects (2003) (76)
- Brain networks in Huntington disease. (2011) (75)
- Parkinson's Disease Spatial Covariance Pattern: Noninvasive Quantification with Perfusion MRI (2010) (75)
- Imaging markers of mild cognitive impairment: Multivariate analysis of CBF SPECT (2007) (75)
- Impaired sequence learning in dystonia mutation carriers: a genotypic effect. (2011) (75)
- Alternating hemichorea in primary antiphospholipid syndrome (1994) (74)
- Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study (2016) (73)
- Radiosynthesis of [18F] N-3-fluoropropyl-2-β-carbomethoxy-3-β-(4-iodophenyl) nortropane and the first human study with positron emission tomography (1996) (72)
- Dopaminergic Suppression of Brain Deactivation Responses during Sequence Learning (2008) (71)
- Abnormal metabolic brain networks in Tourette syndrome (2011) (71)
- Quantification of Parkinson’s disease-related network expression with ECD SPECT (2007) (70)
- Functional neuroimaging in Parkinson's disease. (2012) (70)
- Functional imaging in hereditary dystonia (2010) (70)
- Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography (2008) (67)
- Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing. (1997) (66)
- Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease. (2017) (66)
- Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases (2016) (65)
- Network modulation following sham surgery in Parkinson's disease. (2014) (63)
- Dementia associated with bilateral carotid occlusions: neuropsychological and haemodynamic course after extracranial to intracranial bypass surgery. (1995) (61)
- Dopaminergic correlates of metabolic network activity in Parkinson's disease (2015) (61)
- Combined FDOPA and 3OMFD PET studies in Parkinson's disease. (1996) (60)
- Network correlates of the cognitive response to levodopa in Parkinson disease (2011) (59)
- Preoperative indicators of clinical outcome following stereotaxic pallidotomy (1997) (59)
- The metabolic topography of posthypoxic myoclonus (2004) (59)
- Cognitive functioning after pallidotomy for refractory Parkinson’s disease (1998) (58)
- Identification of disease-related spatial covariance patterns using neuroimaging data. (2013) (58)
- Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease. (1996) (58)
- The metabolic pathology of dopa‐responsive dystonia (2005) (58)
- Abnormal regional brain function in Parkinson's disease: truth or fiction? (2009) (57)
- Parkinson's disease‐related network topographies characterized with resting state functional MRI (2017) (56)
- Cerebral metabolic topography in unilateral temporal lobe epilepsy (1995) (56)
- L-Dopa infusion does not improve explicit sequence learning in Parkinson's disease. (2007) (55)
- Metabolic changes in DYT11 myoclonus-dystonia (2013) (54)
- Improved Sequence Learning with Subthalamic Nucleus Deep Brain Stimulation: Evidence for Treatment-Specific Network Modulation (2012) (54)
- Functional brain networks in movement disorders. (1998) (53)
- Functional Imaging of Cerebral Blood Flow and Glucose Metabolism in Parkinson’s Disease and Huntington’s Disease (2007) (53)
- Neuroimaging in human dystonia. (2005) (53)
- Assessing the microlesion effect of subthalamic deep brain stimulation surgery with FDG PET. (2009) (53)
- Fluorodopa Positron Emission Tomography with an Inhibitor of Catechol-O-Methyltransferase: Effect of the Plasma 3-O-Methyldopa Fraction on Data Analysis (1996) (53)
- Quantitative Brain PET. Comparison of 2D and 3D Acquisitions on the GE Advance Scanner. (1998) (53)
- Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging (2007) (52)
- Metabolic Imaging of Bilateral Anterior Capsulotomy in Refractory Obsessive Compulsive Disorder: an FDG PET Study (2013) (51)
- Functional imaging of sequence learning in Parkinson's disease (2006) (51)
- Anatomic and physiological considerations in pallidotomy for Parkinson's disease. (1995) (51)
- Early Parkinson's disease: Longitudinal changes in brain activity during sequence learning (2010) (51)
- Network correlates of disease severity in multiple system atrophy (2012) (50)
- Pallidal stimulation for Parkinsonism: Improved brain activation during sequence learning (2002) (50)
- Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease. (2008) (50)
- Abnormal metabolic brain network associated with Parkinson’s disease: replication on a new European sample (2017) (49)
- Gene therapy reduces Parkinson’s disease symptoms by reorganizing functional brain connectivity (2018) (48)
- Serotonin Modulation of Cerebral Glucose Metabolism in Depressed Older Adults (2009) (47)
- Early stage Parkinson's disease patients and normal volunteers: Comparative mechanisms of sequence learning (2003) (47)
- The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. (2022) (46)
- Therapeutic effects of human fetal dopamine cells transplanted in a patient with Parkinson's disease. (1990) (46)
- Imaging cerebral function (1993) (46)
- Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression (2011) (46)
- GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop (2020) (45)
- Functional brain imaging of cognitive dysfunction in Parkinson's disease (2012) (45)
- Nervous system dysfunction in Waldenström's macroglobulinemia: Response to treatment (1998) (44)
- Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment. (2019) (44)
- Positron emission tomographic findings in Filipino X‐linked dystonia–parkinsonism (1993) (44)
- The Age-Related Perfusion Pattern Measured With Arterial Spin Labeling MRI in Healthy Subjects (2018) (44)
- Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations (2017) (42)
- Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression. (2002) (42)
- Positron emission tomography studies in parkinsonism. (1992) (42)
- Abnormal Metabolic Pattern Associated with Cognitive Impairment in Parkinson'S Disease: A Validation Study (2015) (42)
- Knowledge gaps and research recommendations for essential tremor. (2016) (41)
- Serotonin modulation of cerebral glucose metabolism in normal aging (2004) (41)
- GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes (2020) (41)
- Temporal lobe epilepsy: Correlation of proton magnetic resonance spectroscopy and 18F‐fluorodeoxyglucose positron emission tomography (1997) (41)
- Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. (2009) (40)
- Modulation of regional brain function by deep brain stimulation: studies with positron emission tomography (2002) (40)
- Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus (2015) (39)
- Network biomarkers for the diagnosis and treatment of movement disorders (2009) (39)
- Network Structure and Function in Parkinson’s Disease (2017) (38)
- Parkinson's Disease—Related Spatial Covariance Pattern Identified with Resting-State Functional MRI (2015) (38)
- Characterization of disease‐related covariance topographies with SSMPCA toolbox: Effects of spatial normalization and PET scanners (2014) (38)
- Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease (2009) (38)
- Functional brain networks in Parkinson's disease. (2001) (37)
- Assessing Cerebral Glucose Metabolism in Patients with Idiopathic Rapid Eye Movement Sleep Behavior Disorder (2015) (37)
- Differences in Regional Brain Activation Patterns Assessed by Functional Magnetic Resonance Imaging in Patients with Systemic Lupus Erythematosus Stratified by Disease Duration (2011) (37)
- Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations (1996) (37)
- Positron emission tomography imaging. (2009) (37)
- Abnormal brain networks in DYT1 dystonia. (1998) (37)
- Brain lactate and N-acetylaspartate in pediatric AIDS encephalopathy. (1998) (36)
- Chronic unilateral optic neuropathy: A magnetic resonance study (1988) (36)
- Evolving metabolic changes during the first postoperative year after subthalamotomy. (2003) (36)
- Effects of posteroventral pallidotomy on Parkinson's disease. (1996) (35)
- Principal Components Analysis of Brain Metabolism Predicts Development of Alzheimer Dementia (2018) (35)
- Effects of levodopa on regional cerebral metabolism and blood flow (2015) (35)
- Thalamocortical Connectivity Correlates with Phenotypic Variability in Dystonia. (2015) (35)
- Effects of levodopa infusion on motor activation responses in Parkinson’s disease (2002) (33)
- Functional brain imaging of movement disorders (2000) (33)
- Functional neuroanatomy of non-verbal semantic sound processing in humans (2006) (33)
- Seizure propagation in a patient with musicogenic epilepsy (2009) (32)
- Metabolic topography of the hemiparkinsonism‐hemiatrophy syndrome (1994) (32)
- Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study (2007) (32)
- Abnormal brain networks in primary torsion dystonia. (2004) (32)
- Parkinson's Disease: Increased Motor Network Activity in the Absence of Movement (2013) (32)
- The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson’s disease and multiple system atrophy (2004) (32)
- Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects. (2003) (31)
- Neuroimaging and therapeutics in movement disorders (2005) (31)
- Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease (2014) (31)
- Abnormal Metabolic Brain Networks in a Nonhuman Primate Model of Parkinsonism (2012) (31)
- Highly automated computer-aided diagnosis of neurological disorders using functional brain imaging (2006) (30)
- 18F-Fluorodeoxyglucose PET in the Evaluation of Parkinson Disease (2010) (30)
- LRRK2 and GBA Variants Exert Distinct Influences on Parkinson's Disease-Specific Metabolic Networks. (2019) (30)
- Superpett 3000 time-of-flight PET tomograph: optimization of factors affecting quantitation (1993) (30)
- Characteristics of pallidal neuronal discharges in Parkinson's disease patients. (1996) (29)
- Dyskinesia Matters (2019) (28)
- Functional brain networks in movement disorders: recent advances. (2012) (28)
- Brain stimulation and functional imaging with fMRI and PET. (2013) (27)
- The Utility of Neuroimaging in the Differential Diagnosis of Parkinsonian Syndromes (2014) (27)
- Basal ganglia lesions after MPTP administration in rhesus monkeys (2006) (26)
- Abnormal metabolic brain networks in Parkinson's disease from blackboard to bedside. (2010) (26)
- Assessing Cerebral Glucose Metabolism in Patients with Idiopathic Rapid Eye Movement Sleep Behavior Disorder (2015) (24)
- Chemotherapy‐induced parkinsonism responsive to levodopa: An underrecognized entity (2003) (24)
- Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts (2018) (24)
- Therapeutic High-Frequency Stimulation of the Subthalamic Nucleus in Parkinson's Disease Produces Global Increases in Cerebral Blood Flow (2012) (24)
- Preoperative response to levodopa is the best predictor of transplant outcome (2004) (24)
- Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia. (2016) (24)
- Dopamine cell transplantation in Parkinson's disease: challenge and perspective. (2011) (23)
- Lid opening apraxia is associated with medial frontal hypometabolism (1995) (23)
- Bladder wall radiation dose in humans from fluorine-18-FDOPA. (1996) (23)
- Cognition following bilateral implants of embryonic dopamine neurons in PD (2003) (23)
- Quantifying Significance of Topographical Similarities of Disease-Related Brain Metabolic Patterns (2014) (23)
- 10 – Movement Disorders: Parkinson's Disease (2000) (22)
- Visualizing the evolution of abnormal metabolic networks in the brain using PET. (1995) (22)
- Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease. (2013) (22)
- Regional brain metabolism in a murine systemic lupus erythematosus model (2014) (22)
- Longitudinal studies of cerebral glucose metabolism in late‐life depression and normal aging (2013) (22)
- Asymmetric predominantly ipsilateral blepharospasm and contralateral parkinsonism in an elderly patient with a right mesencephalic cyst (1998) (22)
- Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting (2018) (22)
- Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia (2017) (22)
- The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson's disease. (2017) (21)
- Waht is it? Case 1, 1990: Progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb (1990) (21)
- FDG PET in the Evaluation of Parkinson's Disease. (2010) (20)
- 19F Imaging of Cerebral Blood Oxygenation in Experimental Middle Cerebral Artery Occlusion: Preliminary Results (1988) (20)
- Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]‐raclopride and positron emission tomography (2009) (20)
- Functional brain imaging in Parkinson's disease. (2003) (19)
- Switching Language Modes: Complementary Brain Patterns for Formulaic and Propositional Language (2018) (19)
- Levodopa‐induced dyskinesias in autopsy‐proven cortical‐basal ganglionic degeneration (2000) (19)
- Synthesis of 6-[18F]fluorodopamine with a synthetic unit made up of primarily sterile disposable components and operated by a master slave manipulator (1993) (19)
- Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia (2019) (19)
- Reproducibility of a Parkinsonism‐related metabolic brain network in non‐human primates: A descriptive pilot study with FDG PET (2015) (19)
- Quantitative brain FDG/PET studies using dynamic aortic imaging. (1994) (19)
- Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation (2016) (19)
- Selection criteria for unilateral posteroventral pallidotomy. (1997) (18)
- A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia (2018) (18)
- Unique white matter structural connectivity in early-stage drug-naive Parkinson disease (2019) (18)
- To scan or not to scan (2012) (17)
- Brain networks and clinical penetrance: lessons from hyperkinetic movement disorders (2003) (17)
- The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging (2014) (17)
- Contralateral temporal hypometabolism on positron emission tomography in temporal lobe epilepsy (1996) (16)
- Metabolic Network Abnormalities in Drug‐Naïve Parkinson's Disease (2019) (16)
- The relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome. (2011) (16)
- Re-Emergent Tremor without Accompanying Rest Tremor in Parkinson’s Disease (2008) (15)
- Understanding the Anatomy of Dystonia: Determinants of Penetrance and Phenotype (2013) (15)
- Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns’ based approach (2020) (15)
- The visual perception of natural motion: abnormal task-related neural activity in DYT1 dystonia. (2015) (15)
- 18FDG-microPET and MR DTI findings in Tor1a+/− heterozygous knock-out mice (2015) (15)
- Increased reaction time predicts visual learning deficits in Parkinson's disease (2010) (15)
- Radiosynthesis of [18F] N-(3-Fluoropropyl)-2-β-Carbomethoxy-3-β-(4-Bromophenyl) Nortropane and the regional brain uptake in non human primate using PET (2004) (14)
- Gene transfer therapy for neurodegenerative disorders (2007) (14)
- Abnormal network topographies and changes in global activity: Absence of a causal relationship (2012) (14)
- Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia. (2017) (14)
- Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson’s disease (2020) (14)
- Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model (2016) (13)
- Neuroimaging and therapeutics in movement disorders (2005) (13)
- Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta (4' methylphenyl) nortropane (FPCMT). (1999) (13)
- Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance (2019) (13)
- Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome. (1993) (13)
- Basal ganglia and kinematics modulation: insights from Parkinson's and Huntington's diseases. (2011) (13)
- The assessment of neurological systems with functional imaging (2007) (12)
- Interactive visualization of coregistered tomographic images (1995) (12)
- Anatomic and physiological considerations in pallidotomy for Parkinson's disease. (1994) (12)
- Using imaging to identify psychogenic parkinsonism before deep brain stimulation surgery. Report of 2 cases. (2012) (12)
- A Full-Brain, Bootstrapped Analysis of Diffusion Tensor Imaging Robustly Differentiates Parkinson Disease from Healthy Controls (2014) (11)
- 12 MICROSTRUCTURAL WHITE MATTER CHANGES IN CARRIERS OF THE DYT1 GENE MUTATION. (2004) (11)
- Early registration of diffusion tensor images for group tractography of dystonia patients (2013) (10)
- Arm tremor secondary to Wilson's disease (1998) (10)
- Can imaging distinguish PSP from other neurodegenerative disorders? (2002) (9)
- Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease (2021) (9)
- Milestones in neuroimaging (2011) (9)
- Three-fold cross-validation of parkinsonian brain patterns (2010) (9)
- Long-term follow-up of a randomized AAV 2-GAD gene therapy trial for Parkinson ’ s disease (2017) (9)
- Dynamic 18F-FPCIT PET: Quantification of Parkinson Disease Metabolic Networks and Nigrostriatal Dopaminergic Dysfunction in a Single Imaging Session (2021) (9)
- The effects of image reconstruction algorithms on topographic characteristics, diagnostic performance and clinical correlation of metabolic brain networks in Parkinson's disease. (2018) (9)
- Cognition-Related Functional Topographies in Parkinson's Disease: Localized Loss of the Ventral Default Mode Network. (2021) (9)
- Imipenem‐induced myoclonus (1997) (9)
- Reproducible metabolic topographies associated with multiple system atrophy: Network and regional analyses in Chinese and American patient cohorts (2020) (8)
- Longitudinal Changes in the Motor Learning-Related Brain Activation Response in Presymptomatic Huntington's Disease (2016) (8)
- Global and multi-focal changes in cerebral blood flow during subthalamic nucleus stimulation in Parkinson’s disease (2017) (8)
- Serotonin modulation of cerebral glucose metabolism: Sex and age effects (2012) (8)
- Oculogyric‐like crises in a 92‐year‐old woman with vascular Parkinsonism (2001) (7)
- Efficacy of bilateral pallidotomy. (1997) (7)
- Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism (2021) (7)
- Anticholinesterase effect on motor kinematic measures and brain activation in Parkinson's disease (2006) (7)
- Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia (2016) (7)
- Assessment of disease progression in parkinsonism (2004) (7)
- Human Radiation Dosimetry for the N-Methyl-d-Aspartate Receptor Radioligand 11C-CNS5161 (2015) (7)
- 75 – PET Imaging in Parkinson's Disease and Other Neurodegenerative Disorders (2007) (7)
- A disposable synthetic unit for the preparation of 3-O-methyl-6-[18F]fluorodopa using a regioselective fluorodemercuration reaction (1994) (7)
- Computer aided diagnosis of functional brain disorders using PET on a PC based platform (2002) (7)
- Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography. (1996) (6)
- Brain Networks of Motor Behavior Assessed by Principal Component Analysis (1998) (6)
- A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism (2022) (6)
- Dopamine modulates striatal response to reward and punishment in patients with Parkinson’s disease: a pharmacological challenge fMRI study (2018) (6)
- Imbalance of the direct and indirect pathways in focal dystonia: a balanced view. (2017) (6)
- Correlation of laparoscopic experience with differential functional brain activation: a positron emission tomography study with oxygen 15-labeled water. (2012) (6)
- Neuroimaging evaluation of deep brain stimulation in the treatment of representative neurodegenerative and neuropsychiatric disorders (2021) (6)
- SPECT imaging in Parkinson's disease. (2001) (5)
- In utero exposure to maternal anti–aquaporin-4 antibodies alters brain vasculature and neural dynamics in male mouse offspring (2022) (5)
- Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries. (2020) (5)
- New Strategies for Automated Differential Diagnosis of Degenerative Brain Disorders (2007) (5)
- Woman with a 26‐year history of parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes (2004) (5)
- Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration (2021) (5)
- Reply to "Transplanted dopaminergic neurons: More or less?" (2001) (5)
- Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation study (2021) (5)
- Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy. (2022) (5)
- Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values (2021) (4)
- Graph Theory-Guided Transcranial Magnetic Stimulation in Neurodegenerative Disorders (2014) (4)
- Positron Emission Tomography and Embryonic Dopamine Cell Transplantation in Parkinson’s Disease (2005) (4)
- Metabolic Networks in Parkinson’s Disease (2013) (4)
- White matter changes in primary dystonia determined by 2D distribution analysis of diffusion tensor images (2013) (4)
- Controversies Arising from Recent FDOPA Articles—Reply (1997) (4)
- Serotonergic pathology and Braak's staging hypothesis in Parkinson's disease (2019) (4)
- Different β-amyloid binding patterns in Alzheimer and Parkinson diseases (2013) (4)
- Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesia (2021) (4)
- Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography (2022) (4)
- Atypical clinical presentation of pathologically proven Parkinson's disease: The role of Parkinson's disease related metabolic pattern. (2020) (3)
- Stimulation of the Subthalamic Nucleus Changes Cortical-Subcortical Blood Flow Patterns During Speech: A Positron Emission Tomography Study (2021) (3)
- Disruption of network for visual perception of natural motion in primary dystonia (2018) (3)
- Network Imaging in Parkinsonian and Other Movement Disorders: Network Dysfunction and Clinical Correlates. (2019) (3)
- Functional Imaging of Cognitive Impairment in Parkinson's Disease (2010) (3)
- Prospective FDOPA PET imaging study in human PD :our final step towards NDA approval (2020) (3)
- Neurodegenerative Diseases: PET/SPECT (2005) (3)
- Adaptive and pathological connectivity responses in Parkinson's disease brain networks. (2021) (3)
- Testing a test for Alzheimer disease (2007) (3)
- Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients (2022) (3)
- Abnormal topography of cerebral glucose metabolism in parkinsonian macaques: A FDG PET study (2010) (3)
- The metabolic landscape of Parkinson's disease. (1999) (2)
- Abnormal metabolic brain networks in Parkinsons disease (2010) (2)
- Inaugural Huntington Disease Clinical Research Symposium Organized by the Huntington Study Group (2011) (2)
- Cerebral Glucose Metabolism and Blood Flow in Parkinson’s Disease (2011) (2)
- Brain Imaging as a Diagnostic Tool (2002) (2)
- Imaging in Parkinson's Disease (2011) (2)
- Association between reduced striatal D2 receptor binding and the estimated time to onset in presymptomatic Huntington's disease: A longitudinal RAC/PET study over 4 years (2006) (1)
- Prospective F-18 FDOPA PET Imaging Study in Human PD (2022) (1)
- Akathisia in Parkinson's disease : A preliminary study (1996) (1)
- Fetal neural implants for Paridnson's disease: results at six months and one year (1990) (1)
- PET Imaging in Movement Disorders (2010) (1)
- Radiation Absorbed Dose to the Basal Ganglia from Dopamine Transporter Radioligand 18F-FPCIT (2014) (1)
- PET and SPECT Imaging in Parkinsonian Syndromes (2014) (1)
- Comparison of Mapping Parameters in [18F]FPCIT Imaging of Early Stage Parkinson's Disease (2002) (1)
- Radiomics and supervised machine learning in the diagnosis of parkinsonism with FDG PET: promises and challenges (2020) (1)
- Visualizing Network Connectivity in Parkinson'S Disease (2018) (1)
- Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia (2022) (1)
- Poster 12: A Metabolic Network Associated with the Progression of Preclinical Huntington's Disease: Application of the Ordinal Trends Analysis to a Longitudinal PET Study (2009) (1)
- Correlation between metabolic and CSF biomarkers in Alzheimer's disease patients with early cognitive decline (2015) (1)
- METABOLIC BRAIN PATTERN OF CREUTZFELDT-JAKOB DISEASE AND ITS BIOLOGICAL SIGNIFICANCE (2019) (1)
- Radiosynthesis of [18F] N-(3-Fluoropropyl)-2-beta-Carbomethoxy-3-beta-(4-Bromophenyl) Nortropane and the regional brain uptake in non human primate using PET. (2004) (1)
- FRI0283 Dynamic contrast enhanced mri (DCE-MRI) demonstrates hippocampus permeability in sle (2018) (1)
- Parkinson ’ s disease – related spatial covariance pattern identi fi ed with resting-state functional MRI (2017) (1)
- Comprar Imaging in Parkinson's Disease | David Eidelberg | 9780195393484 | Oxford University Press (2011) (1)
- ⎣ ⎦ ⎣ ⎦ ⎣ ⎦ 2 D distribution analysis of DTI in two phenotypes of dystonia patients (2009) (1)
- Multivariate analysis: Applications to the study of hereditary movement disorders (2007) (1)
- Visualizing patterns of neurological disease progression with PET (1994) (1)
- Visuo-computational tools for PET physiological imaging (1991) (1)
- Functional imaging in Huntington disease. (2017) (1)
- MONITORING THE PROGRESSION OF DEMENTIA USING FGD-PET BRAIN IMAGING AND NETWORK ANALYSIS: ROLE OF THE ALZHEIMER’S DISEASE-RELATED PATTERN (2017) (1)
- Assessing the progression of Parkinson’s disease: A metabolic network approach therapy on PD-related (2010) (1)
- ABNORMAL METABOLIC NETWORK ACTIVITY IN PARKINSON'S DISEASE WITH GBA VARIANTS (2018) (1)
- Functional Imaging Biomarkers for the Assessment of Parkinson’s Disease Progression (2011) (1)
- Functional Neuroimaging (2019) (1)
- Stereotyped Relationship Between Motor and Cognitive Metabolic Networks in Parkinson's Disease (2022) (1)
- Multivariate brain mapping in clinical neuroscience research (2007) (1)
- Abnormal metabolic brain network in behavioral variant of frontotemporal dementia (2021) (1)
- maternal genes Mom and me : Brain metabolism links Alzheimer disease to (2009) (0)
- 迅速な繰り返しのPET研究のための[15O]‐H2O調製のための装置 (1999) (0)
- Editorial introductions. (2020) (0)
- Thelamic Stimulation for Parkinsonian Tremor (2002) (0)
- Positron Emission Tomography in Surgery for Movement Disorders (2003) (0)
- Reduced dopamine D2 receptor binding in striatal subregions in presymptomatic Huntington's disease: A longitudinal raclopride PET study over 7 years (2011) (0)
- Differences of cerebral perfusion between subtype of multiple system atrophy with predominant cerebellar ataxia and with predominant parkinsonism (2020) (0)
- In memoriam Professor Edward Robert Hitchcock. NECTAR members. (1994) (0)
- Correlation between metabolic and CSF biomarkers in Alzheimer's disease patients with early cognitive decline (2015) (0)
- Polyradiculoneuropathy, polyradiculitis, and CMV in AIDS and ARC (1987) (0)
- Accurate differential diagnosis of parkinsonism by pattern analysis of metabolic imaging data (2010) (0)
- Vigabatrin (GVG) blocks optiate induced decreases in FDG uptake (2011) (0)
- MONITORING THE PROGRESSION OF DEMENTIA USING FDG-PET BRAIN IMAGING AND NETWORK ANALYSIS: ROLE OF THE ALZHEIMER’S DISEASE-RELATED PATTERN (2017) (0)
- Functional Imaging of the Basal Ganglia (2000) (0)
- Reply to: Letter to Editor by Chaudhuri, Jenner, Antonini (2020) (0)
- Global and multifocal changes in cerebral blood flow during subthalamic nucleus stimulation in Parkinson ’ s disease (2019) (0)
- Validation of the Alzheimer’s dementia conversion-related pattern as a biomarker of neurodegeneration within the NIA-AA research framework (2020) (0)
- 43. Surgical therapies for parkinson's disease: Embryonic nigral grafts and pallidal ablation (1996) (0)
- PET and SPECT Imaging in Atypical Parkinsonian Syndromes (2020) (0)
- An acute dose of racemic gamma vinyl-GABA (GVG) attenuates the acute effects of morphine on brain metabolism and behavior in young adult animals (2012) (0)
- Disruption of cerebellar-thalamo-cortical connections correlate closely with motor activation (2009) (0)
- FV2. Cognition-related Parkinson’s disease pattern with functional MRI: Validation and clinical correlates (2018) (0)
- Correction of Brain Atrophy in Metabolic Imaging of Presymptomatic Huntington’s Disease: A Combined FDG PET and MRI Study (2008) (0)
- 2.022 EFFECT OF PRAMIPEXOLE ON REGIONAL CEREBRAL BLOOD FLOW IN PARKINSON'S DISEASE (2012) (0)
- Neuroimaging evaluation of deep brain stimulation in the treatment of representative neurodegenerative and neuropsychiatric disorders (2021) (0)
- Test-Retest Reliability and Prospective Validation of an Abnormal Metabolic Network of Premanifest Huntington's Disease (S20.001) (2013) (0)
- Abnormal metabolic brain networks in progressive supranuclear palsy and corticobasal syndrome: diagnostic performance using perfusion spect scans in patients with movement disorders (2017) (0)
- Patterns of brain activation in motor sequence learning: 15O-H2O/PET studies (1996) (0)
- Commentary on: A Network Approach to Understanding the Effects of Focused Ultrasound for Essential Tremor: Insights into Pathophysiology, Treatment, and Imaging Biomarkers (2022) (0)
- Sporadic Creutzfeldt–Jakob disease is associated with reorganization of metabolic connectivity in a pathological brain network (2022) (0)
- Functional imaging in primary dystonia (2007) (0)
- Mapping Progression of White Matter Atrophy in Presymptomatic Huntington's Disease Gene Carriers: A Longitudinal MRI Study (2009) (0)
- Characteristic metabolic brain pattern in Slovenian Parkinson's disease patients (2016) (0)
- SIMILAR METABOLIC BRAIN CHARACTERISTICS OF DEMENTIA WITH LEWY BODIES AND PARKINSON’S DISEASE DEMENTIA (2018) (0)
- Longitudinal Changes in Metabolic Network Activity Associated with the Progression of Alzheimer’s Disease (P3.187) (2018) (0)
- Longitudinal changes in the expression of Alzheimer’s disease‐related pattern and default mode network (2022) (0)
- Poster 11: Motor Symptom–Related Metabolic Network in Huntington's Disease (2009) (0)
- Authors' Reply (1994) (0)
- A comparative F-dopa and FDG PET study of parkinsonian subjects without evidence of dopaminergic dysfunction (2005) (0)
- Test-retest reproducibility of a progression-related pattern (HDPP) in premanifest Huntington's disease: A multicenter pilot study with FDG PET (2012) (0)
- Abnormal covariance metabolic topography in patients with progressive supranuclear palsy: A FDG PET study (2005) (0)
- Neural correlates of opiate abuse differ in adolescent compared to adult animals (2011) (0)
- 91. Increased activation of cingulate and association cortices in the manic state (1998) (0)
- Associations between a measure of brain network metabolic activity and non-motor measures of Parkinson's disease (2009) (0)
- Functional brain networks in the evaluation of patients with neurodegenerative disorders (2022) (0)
- Reproducibility of Parkinson’s disease-related metabolic brain networks across four countries (2013) (0)
- DECREASED ORBITOFRONTAL ACTIVATION IN MANIA: AN H2150 PET ACTIVATION STUDY (1998) (0)
- 14 EARLY PD: LONGITUDINAL CHANGES IN MOVEMENT AND ASSOCIATED BRAIN ACTIVATION. (2004) (0)
- Editorial: introducing the new Co-Editors-in-Chief of Current Opinion in Neurology. (2017) (0)
- Validation of a Dynamic PET Simulator in Clinical Brain Studies (2001) (0)
- LAPAROSCOPIC EXPERIENCE CORRELATES WITH DIFFERENTIAL FUNCTIONAL BRAIN ACTIVATION: AN OXYGEN-15 LABELED PET SCAN STUDY (2009) (0)
- A distinct pattern of altered pathway microstructure in inherited and sporadic dystonia (2017) (0)
- Parkinsonian differentiation using PCA image correlation scores (2015) (0)
- Brain Network Metabolic Changes in Patients with Parkinsonian Tremors (2016) (0)
- Metabolic Changes in the Supplementary Motor Area in the Treatment of Parkinson's Disease (P06.082) (2013) (0)
- Book Review Movement Disorders: Neurologic principles and practice Edited by Ray L. Watts and William C. Koller. 779 pp., illustrated. New York, McGraw-Hill, 1997. $125. 0-07-035203-8 (1997) (0)
- Parkinson's Disease Metabolic Network Predicts Phenoconversion in Patients with Idiopathic REM Sleep Behavior Disorder (S19.004) (2013) (0)
- Reduced hippocampal-thalamic fiber tracts in Systemic Lupus Erythematosus (2017) (0)
- P3.133 Regulation of movement energetic costs is impaired in basal ganglia disorders (2009) (0)
- TREMOR (1996) (0)
- Alzheimer's disease without amnesia: A case study with neuropsychological and PET findings with biopsy-verification (1999) (0)
- Mom and me (2009) (0)
- Mapping abnormal metabolic brain function in parkinsonian macaques: A FDG PET study (2008) (0)
- Impaired Striatal and Preserved Prefrontal Dopamine Release in Advanced PD (2003) (0)
- Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia (2017) (0)
- Second Annual Huntington Disease Clinical Research Symposium (2011) (0)
- Contributors (1981) (0)
- Differential brain metabolism following single vs. repeated ethanol exposures in adolescent rat: A [18F]fluorodeoxyglucose-PET study (2011) (0)
- Small animal PET provides insights into the effects of an acute opiate challenge on brain metabolism and behavior in adolescent versus adult animals (2012) (0)
- PET Applications to Surgical Treatment of Parkinson's Disease (2000) (0)
- O.069 Neuroimaging in Parkinson's disease (2009) (0)
- Poster Presentations (2023) (0)
- Longitudinal changes in the expression of Alzheimer’s disease‐related pattern and default mode network (2022) (0)
- SSMPCA Toolbox: An Automated Computing Platform for Analyzing Brain Imaging Data (2009) (0)
- 1.197 Sequence learning and the basal ganglia (2007) (0)
- Prof. E. Hitchcock (1994) (0)
- Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease (2014) (0)
- 13th Meeting of the Network of European CNS Transplantation and Restoration (NECTAR). (2003) (0)
- Longitudinal study of FP-CIT and ECD SPECT in Parkinson's disease and essential tremor (2009) (0)
- Speaker abstracts from the ASENT 2005 Annual Meeting March 3–5, 2005 (2005) (0)
- 338. L-DOPA effect on connectivity within motor CSPTC loop in Parkinson’s disease (2000) (0)
- 1900 The expression of normal motor-related functional pattern using fMRI and PET in sporadic dystonia (2013) (0)
- Subject Index Vol. 62, 1994 (1994) (0)
- Disordered network structure and function in dystonia: pathological connectivity vs. adaptive responses. (2023) (0)
- Brain Correlates of Neuropsychological Function in Presymptomatic HD Gene Carriers (2008) (0)
- Disruption of natural motion perception in dystonia patients with DYT 1 mutation (2012) (0)
- SIMILAR METABOLIC BRAIN CHARACTERISTICS OF DEMENTIA WITH LEWY BODIES AND PARKINSON’S DISEASE DEMENTIA (2018) (0)
- Platform Presentation—Loss of Striatal Dopaminergic Function and Thalamic Compensatory Mechanism During Phenocoversion of Preclinical Huntington's Disease (2009) (0)
- 101 Increased blood brain barrier permeability associates with increased hippocampal glucose metabolism in SLE (2021) (0)
- Functional Imaging to Study Movement Disorders (2015) (0)
- Use of positron-emission tomography as a diagnostic and differential diagnostic tool in parkinsonian syndromes (2020) (0)
- Imaging in Tourette’s Syndrome (2004) (0)
- An apparatus for the preparation of [15O]-H2O for rapid repetitive PET studies (2008) (0)
- 35 METABOLIC NETWORK MODULATION WITH SUBTHALAMIC DEEP BRAIN STIMULATION FOR PARKINSON'S DISEASE. (2004) (0)
- Mapping the relationship between {beta}-amyloid load and cognition-related metabolic activity in Parkinson's disease: [11C]-PIB and [18F]-FDG PET studies (2010) (0)
- Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease (2021) (0)
- Editorial introductions. (2018) (0)
- Imaging, Cognition, and Parkinson's Disease—An Overview (2010) (0)
- 727. Improvements in Clinical and Radiographic Outcomes in a Phase I Study of AAV-GAD Gene Therapy for Parkinson's Disease (2006) (0)
- Reviewing Editors (2016) (0)
- Positron emission tomography (PET) as a technique for studying patterns of regional cerebral function associated with auditory perception and speech production (1988) (0)
- Automated differential diagnosis of dementia syndromes using FDG PET and machine learning (2022) (0)
- Reproducibility of parkinsonism-related metabolic brain network activity in the USA and China (2013) (0)
This paper list is powered by the following services:
Other Resources About David Eidelberg
What Schools Are Affiliated With David Eidelberg?
David Eidelberg is affiliated with the following schools: